Extrawell Pharmaceutical Holdings Limited (0858.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 198.32M |
| Enterprise Value | 256.97M |
| P/E Ratio | -0.19 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 3.57 |
| Price/Book Ratio | 0.51 |
| Enterprise/Revenue | 4.71 |
| Enterprise/EBITDA | -88.99 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -19.03 |
| Operating Margin | -0.19 |
AD
Management Effectiveness
| Return On Assets | -1.67 |
| Return On Equity | -1.55 |
Income Statement
| Revenue | 51.48M |
| Revenue/Share | 0.02 |
| Gross Profit | 22.75M |
| EBITDA | -1.77M |
| Net Income | -979.71M |
| Diluted EPS | -0.4 |
Balance Sheet
| Total Cash | 214.16M |
| Total Cash/Share | 0.08 |
| Total Debt | 169.33M |
| Total Debt/Equity | 0.45 |
| Current Ratio | 6.04 |
| Book Value Per Share | 0.15 |
Price History
| 52-Week Change | -43.18 |
| 52-Week High | 0.14 |
| 52-Week Low | 0.05 |
| Moving Average 50 Days | 0.07 |
| Moving Average 200 Days | 0.08 |
Statistics
| Average Volume | 1.75M |
| Shares Outstanding | 2.45B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
